{"id":203440,"date":"2020-09-14T00:29:27","date_gmt":"2020-09-13T23:29:27","guid":{"rendered":"https:\/\/tucuentavip.com\/es\/?p=203440"},"modified":"2020-09-12T20:40:42","modified_gmt":"2020-09-12T19:40:42","slug":"industria-farmaceutica-mayor-pandemia-mayor-ganancia","status":"publish","type":"post","link":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/","title":{"rendered":"Industria farmac\u00e9utica: mayor pandemia, mayor ganancia"},"content":{"rendered":"<p><em>En medio mentiras, pol\u00edtica y codicia, emergen los intereses de grandes farmac\u00e9uticas como Novartis, Roche, Pfizer, Astrazeneca, Roche y Johnson &amp; Johnson, entre otras, que pugnan con nuevas compa\u00f1\u00edas de la biotecnolog\u00eda como Gilead Sciences, Inc para frenar a la Covid-19.<\/em><\/p>\n<p><em><br \/>\n<\/em><\/p>\n<p><a href=\"http:\/\/Nubia Piqueras Grosso\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-203474 alignleft\" src=\"https:\/\/tucuentavip.com\/wp-content\/uploads\/2020\/09\/Farmaceutica-medici-droga-indus-Pixabay-1024x576.jpg\" alt=\"\" width=\"408\" height=\"229\" \/>Nubia Piqueras Grosso <\/strong><\/a><\/p>\n<p><em>\u00a0<\/em><\/p>\n<p>Con una capitalizaci\u00f3n cercana a los US$100 mil millones, Gilead era una desconocida para el gran p\u00fablico hasta que su f\u00e1rmaco Remdesivir salt\u00f3 a los titulares en medio de la pandemia y dispar\u00f3 la cotizaci\u00f3n de este f\u00e1rmaco de US$65 a comienzos de 2020 a US$83.<br \/>\nLa compa\u00f1\u00eda, fundada en 1987, es hoy un referente en el desarrollo de medicamentos antirretrovirales para tratar pacientes infectados con VIH, hepatitis B o influenza; mientras que la centenaria Abbott, un laboratorio estadounidense que seduce a los expertos, tiene una capitalizaci\u00f3n burs\u00e1til de US$170 mil millones, tras revalorizarse un 10%.<\/p>\n<p>Por su parte, la farmac\u00e9utica suiza Roche anunci\u00f3 recientemente que desarroll\u00f3 una prueba de anticuerpos para la Covid-19, lo que dispar\u00f3 las acciones de la firma en cerca de un 2% y le permiti\u00f3 facturar\u00a0 57.300 millones de euros y logr\u00f3 un beneficio de 13.146 millones de euros durante el 2019, seg\u00fan reportes de medios de prensa.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-199015\" src=\"https:\/\/tucuentavip.com\/wp-content\/uploads\/2020\/03\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg\" alt=\"\" width=\"403\" height=\"564\" srcset=\"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/03\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg 467w, https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/03\/La-pandemia-coronavirus-cara-oscuridad-Pixabay-143x200.jpg 143w, https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/03\/La-pandemia-coronavirus-cara-oscuridad-Pixabay-39x55.jpg 39w\" sizes=\"auto, (max-width: 403px) 100vw, 403px\" \/>En esta lista de compa\u00f1\u00edas farmac\u00e9uticas altamente lucrativas hay otras como Translate Bio, a la b\u00fasqueda de una cura eficaz gracias a los genes; Akers Biosciences, la firma que se dispar\u00f3 un 344% tras anunciar un avance en el camino hacia la vacuna de la Covid-19 cuando junto a Premas Biotech consigui\u00f3 clonar con \u00e9xito todos los ant\u00edgenos del coronavirus que fueron seleccionados como candidatos a la creaci\u00f3n de una vacuna.<\/p>\n<p>Tambi\u00e9n aparece la francesa Sanofi, responsable de producir la hidroxicloroquina, que en su guerra contra la pandemia y por encontrar una vacuna se ali\u00f3 con otras firmas como Translate Bio o el tambi\u00e9n gigante brit\u00e1nico GSK.<\/p>\n<p>Se suman, adem\u00e1s, la estadounidense Pfizer, que ataca a la Covid-19 desde diferentes \u00e1ngulos, entre ellos con un inyectable gracias a la alianza con la empresa alemana BioNTech.<\/p>\n<p>Novacyt, una peque\u00f1a empresa a la que la crisis sanitaria provocada por la pandemia catapult\u00f3 en la Bolsa con el anunci\u00f3 de un test molecular para diagnosticar el nuevo coronavirus y la espa\u00f1ola Grifols, especializada en la producci\u00f3n de hemoderivados, trata de competir con un plasma anticoronavirus para pacientes curados. Llama la atenci\u00f3n que algunas de estas firmas han vuelto a respirar gracias a la pandemia, pues las estad\u00edsticas reflejan p\u00e9rdidas econ\u00f3micas y d\u00e9ficits acumulados durante a\u00f1os.<\/p>\n<p>Es el caso de Akers Biosciences, cuyos ingresos cayeron un 5% en 2019; sin embargo, este a\u00f1o ya acumula una subida del 30%.<\/p>\n<p>No quedan dudas de que el negocio de la salud y de la industria farmac\u00e9utica es el tercer sector de la econom\u00eda en el mundo (tiene un mercado de US$1,3 millones de millones, detr\u00e1s del armamento y el narcotr\u00e1fico.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-200339 alignleft\" src=\"https:\/\/tucuentavip.com\/wp-content\/uploads\/2020\/05\/Covid-dinero-socied-viejos-ancia-virus-Pixabay-4.jpg\" alt=\"\" width=\"403\" height=\"252\" srcset=\"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/05\/Covid-dinero-socied-viejos-ancia-virus-Pixabay-4.jpg 960w, https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/05\/Covid-dinero-socied-viejos-ancia-virus-Pixabay-4-300x188.jpg 300w, https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/05\/Covid-dinero-socied-viejos-ancia-virus-Pixabay-4-88x55.jpg 88w, https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/05\/Covid-dinero-socied-viejos-ancia-virus-Pixabay-4-650x406.jpg 650w\" sizes=\"auto, (max-width: 403px) 100vw, 403px\" \/>Y en Estados Unidos sus beneficios son cuatro veces superiores al del resto de los sectores industriales.<\/p>\n<p>Tanto es as\u00ed, que las corporaciones estadounidenses no solo recibieron m\u00e1s de US$8.300 millones para el desarrollo de la vacuna contra el nuevo coronavirus, sino que poseen la autoridad de establecer el precio y determinar su distribuci\u00f3n, de manera que sus intereses comerciales est\u00e1n por encima de las prioridades de salud de las personas.<\/p>\n<p>Sin embargo, la vacuna rusa Sputnik V es hoy la piedra en el zapato, pues tras su anuncio llegaron pedidos procedentes de 20 pa\u00edses y con ello la ca\u00edda de las acciones de Pfizer (0,8%), Novavax (7,7%) y Moderna (2,5%) como refieren reportes de prensa especializados.<\/p>\n<p>Vale destacar que las tres corporaciones est\u00e1n incluidas en la lista de la Organizaci\u00f3n Mundial de la Salud como creadoras de una vacuna contra la Covid-19 que est\u00e1 en fase tres de ensayos cl\u00ednicos, en la que se eval\u00faa la seguridad y eficacia del producto.<\/p>\n<p><a href=\"http:\/\/Nubia Piqueras Grosso\"><strong><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-161644 alignleft\" src=\"https:\/\/tucuentavip.com\/wp-content\/uploads\/2016\/02\/El-sue\u00f1o-americano-6-e1558279956451.jpg\" alt=\"\" width=\"406\" height=\"270\" \/><\/strong><\/a>Por lo pronto, los rusos anunciaron que empezar\u00e1n la vacunaci\u00f3n voluntaria masiva a partir del pr\u00f3ximo 1 de octubre, mientras que recientemente medios de prensa revelaron que la vacuna creada por la corporaci\u00f3n Moderna no estar\u00e1 lista antes del 3 de noviembre como espera el presidente estadounidense, Donald Trump, sino para inicios de 2021. <a href=\"http:\/\/prensa-latina.cu\/\">(PL)<\/a><\/p>\n<p><a href=\"http:\/\/pixabay,com\"><em>(Fotos: Pixabay)<\/em><\/a><\/p>\n<div class=\"twttr_buttons\"><div class=\"twttr_twitter\">\n\t\t\t\t\t<a href=\"http:\/\/twitter.com\/share?text=Industria+farmac%C3%A9utica%3A+mayor+pandemia%2C+mayor+ganancia\" class=\"twitter-share-button\" data-via=\"\" data-hashtags=\"\"  data-size=\"default\" data-url=\"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/\" data-dnt=\"true\" data-related=\"\" target=\"_blank\">Tweet<\/a>\n\t\t\t\t<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>En medio mentiras, pol\u00edtica y codicia, emergen los intereses de grandes farmac\u00e9uticas como Novartis, Roche, Pfizer, Astrazeneca, Roche y Johnson &amp; Johnson, entre otras, que pugnan con nuevas compa\u00f1\u00edas de la biotecnolog\u00eda como Gilead Sciences, Inc para frenar a la Covid-19. Nubia Piqueras Grosso \u00a0 Con una capitalizaci\u00f3n cercana a [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":199015,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10,11,15],"tags":[],"class_list":["post-203440","post","type-post","status-publish","format-standard","has-post-thumbnail","category-globo","category-mundo","category-reino-unido"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Industria farmac\u00e9utica: mayor pandemia, mayor ganancia - ThePrisma.co.uk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Industria farmac\u00e9utica: mayor pandemia, mayor ganancia - ThePrisma.co.uk\" \/>\n<meta property=\"og:description\" content=\"En medio mentiras, pol\u00edtica y codicia, emergen los intereses de grandes farmac\u00e9uticas como Novartis, Roche, Pfizer, Astrazeneca, Roche y Johnson &amp; Johnson, entre otras, que pugnan con nuevas compa\u00f1\u00edas de la biotecnolog\u00eda como Gilead Sciences, Inc para frenar a la Covid-19. Nubia Piqueras Grosso \u00a0 Con una capitalizaci\u00f3n cercana a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/\" \/>\n<meta property=\"og:site_name\" content=\"ThePrisma.co.uk\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ThePrismaTheMulticulturalNewspaper\" \/>\n<meta property=\"article:published_time\" content=\"2020-09-13T23:29:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/03\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"467\" \/>\n\t<meta property=\"og:image:height\" content=\"653\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"ThePrisma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@The_Prisma\" \/>\n<meta name=\"twitter:site\" content=\"@The_Prisma\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"ThePrisma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/\"},\"author\":{\"name\":\"ThePrisma\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#\\\/schema\\\/person\\\/24f5091d3dc50052d73cbea6ecd09df7\"},\"headline\":\"Industria farmac\u00e9utica: mayor pandemia, mayor ganancia\",\"datePublished\":\"2020-09-13T23:29:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/\"},\"wordCount\":729,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg\",\"articleSection\":[\"Globo\",\"Mundo\",\"Reino Unido\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/\",\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/\",\"name\":\"Industria farmac\u00e9utica: mayor pandemia, mayor ganancia - ThePrisma.co.uk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg\",\"datePublished\":\"2020-09-13T23:29:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg\",\"contentUrl\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg\",\"width\":467,\"height\":653},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/2020\\\/09\\\/14\\\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/theprisma.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Industria farmac\u00e9utica: mayor pandemia, mayor ganancia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/\",\"name\":\"ThePrisma.co.uk\",\"description\":\"Ethical and Independent Journalism\u2026 Journalism for immigrants\",\"publisher\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/theprisma.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#organization\",\"name\":\"ThePrisma.co.uk\",\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Logo-TP-May-3-2026.jpg\",\"contentUrl\":\"https:\\\/\\\/theprisma.co.uk\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Logo-TP-May-3-2026.jpg\",\"width\":2171,\"height\":353,\"caption\":\"ThePrisma.co.uk\"},\"image\":{\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ThePrismaTheMulticulturalNewspaper\",\"https:\\\/\\\/x.com\\\/The_Prisma\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/theprisma.co.uk\\\/#\\\/schema\\\/person\\\/24f5091d3dc50052d73cbea6ecd09df7\",\"name\":\"ThePrisma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g\",\"caption\":\"ThePrisma\"},\"url\":\"https:\\\/\\\/theprisma.co.uk\\\/es\\\/author\\\/theprisma\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Industria farmac\u00e9utica: mayor pandemia, mayor ganancia - ThePrisma.co.uk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/","og_locale":"es_ES","og_type":"article","og_title":"Industria farmac\u00e9utica: mayor pandemia, mayor ganancia - ThePrisma.co.uk","og_description":"En medio mentiras, pol\u00edtica y codicia, emergen los intereses de grandes farmac\u00e9uticas como Novartis, Roche, Pfizer, Astrazeneca, Roche y Johnson &amp; Johnson, entre otras, que pugnan con nuevas compa\u00f1\u00edas de la biotecnolog\u00eda como Gilead Sciences, Inc para frenar a la Covid-19. Nubia Piqueras Grosso \u00a0 Con una capitalizaci\u00f3n cercana a [&hellip;]","og_url":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/","og_site_name":"ThePrisma.co.uk","article_publisher":"https:\/\/www.facebook.com\/ThePrismaTheMulticulturalNewspaper","article_published_time":"2020-09-13T23:29:27+00:00","og_image":[{"width":467,"height":653,"url":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/03\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg","type":"image\/jpeg"}],"author":"ThePrisma","twitter_card":"summary_large_image","twitter_creator":"@The_Prisma","twitter_site":"@The_Prisma","twitter_misc":{"Escrito por":"ThePrisma","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/#article","isPartOf":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/"},"author":{"name":"ThePrisma","@id":"https:\/\/theprisma.co.uk\/#\/schema\/person\/24f5091d3dc50052d73cbea6ecd09df7"},"headline":"Industria farmac\u00e9utica: mayor pandemia, mayor ganancia","datePublished":"2020-09-13T23:29:27+00:00","mainEntityOfPage":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/"},"wordCount":729,"commentCount":0,"publisher":{"@id":"https:\/\/theprisma.co.uk\/#organization"},"image":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/#primaryimage"},"thumbnailUrl":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/03\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg","articleSection":["Globo","Mundo","Reino Unido"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/","url":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/","name":"Industria farmac\u00e9utica: mayor pandemia, mayor ganancia - ThePrisma.co.uk","isPartOf":{"@id":"https:\/\/theprisma.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/#primaryimage"},"image":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/#primaryimage"},"thumbnailUrl":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/03\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg","datePublished":"2020-09-13T23:29:27+00:00","breadcrumb":{"@id":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/#primaryimage","url":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/03\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg","contentUrl":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2020\/03\/La-pandemia-coronavirus-cara-oscuridad-Pixabay.jpg","width":467,"height":653},{"@type":"BreadcrumbList","@id":"https:\/\/theprisma.co.uk\/es\/2020\/09\/14\/industria-farmaceutica-mayor-pandemia-mayor-ganancia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/theprisma.co.uk\/"},{"@type":"ListItem","position":2,"name":"Industria farmac\u00e9utica: mayor pandemia, mayor ganancia"}]},{"@type":"WebSite","@id":"https:\/\/theprisma.co.uk\/#website","url":"https:\/\/theprisma.co.uk\/","name":"ThePrisma.co.uk","description":"Ethical and Independent Journalism\u2026 Journalism for immigrants","publisher":{"@id":"https:\/\/theprisma.co.uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/theprisma.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/theprisma.co.uk\/#organization","name":"ThePrisma.co.uk","url":"https:\/\/theprisma.co.uk\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/theprisma.co.uk\/#\/schema\/logo\/image\/","url":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2026\/05\/Logo-TP-May-3-2026.jpg","contentUrl":"https:\/\/theprisma.co.uk\/wp-content\/uploads\/2026\/05\/Logo-TP-May-3-2026.jpg","width":2171,"height":353,"caption":"ThePrisma.co.uk"},"image":{"@id":"https:\/\/theprisma.co.uk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ThePrismaTheMulticulturalNewspaper","https:\/\/x.com\/The_Prisma"]},{"@type":"Person","@id":"https:\/\/theprisma.co.uk\/#\/schema\/person\/24f5091d3dc50052d73cbea6ecd09df7","name":"ThePrisma","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0460a803edadc6b8d142ee19ab9952aeb8d3949d4a75e483f11d805b0fa0621e?s=96&d=mm&r=g","caption":"ThePrisma"},"url":"https:\/\/theprisma.co.uk\/es\/author\/theprisma\/"}]}},"_links":{"self":[{"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/posts\/203440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/comments?post=203440"}],"version-history":[{"count":5,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/posts\/203440\/revisions"}],"predecessor-version":[{"id":203484,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/posts\/203440\/revisions\/203484"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/media\/199015"}],"wp:attachment":[{"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/media?parent=203440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/categories?post=203440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theprisma.co.uk\/es\/wp-json\/wp\/v2\/tags?post=203440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}